Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Symecko

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
JCO Precision Oncology|August 3, 2023
Biallelic <i>BRCA</i> Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline <i>BRCA1/2</i> CarriersDylane Wineland, Anh N Le, Ryan Hausler, et al.
BMC Medical Research Methodology|August 19, 2020
Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trialLydia E Pace, Yeonsoo S Lee, Nadine Tung, et al.
The Journal of Urology|March 28, 2023
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer PatientsKelsey E Breen, Heather Symecko, Kelsey Spielman, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Journal of General Internal Medicine|June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR StudyLydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancerJada G Hamilton, Heather Symecko, Kelsey Spielman, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patientsTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2026
Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate CancerTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort studyKelly M Morgan, Jada G Hamilton, Heather Symecko, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
JCO Precision Oncology|August 3, 2023
Biallelic <i>BRCA</i> Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline <i>BRCA1/2</i> CarriersDylane Wineland, Anh N Le, Ryan Hausler, et al.
BMC Medical Research Methodology|August 19, 2020
Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trialLydia E Pace, Yeonsoo S Lee, Nadine Tung, et al.
The Journal of Urology|March 28, 2023
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer PatientsKelsey E Breen, Heather Symecko, Kelsey Spielman, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Journal of General Internal Medicine|June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR StudyLydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancerJada G Hamilton, Heather Symecko, Kelsey Spielman, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patientsTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2026
Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate CancerTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort studyKelly M Morgan, Jada G Hamilton, Heather Symecko, et al.
Pageof 3